ZVRA R&D Expense Growth
Zevra Therapeutics Inc · R&D Expense Growth

ZVRA R&D Expense Growth
Latest reported-69.73%period ending
ZVRA FY R&D Growth (YoY) (0.00% → -69.73%)
Latest values, visible window
High-resolution chart · PNG
ZVRA r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -69.728% | |
| 5.7504% | |
| 101.0099% | |
| 94.8922% | |
| 14.9044% | |
| -54.4527% | |
| -53.507% | |
| 102.7825% | |
| 0.5911% | |
| 46.9528% | |
| 16.8981% | |
| 253.9417% | |
| 12.431% | |
| 0% |